Anti-Mouse F4/80 Antibody [BM8]
Anti-Mouse F4/80 Antibody [BM8] with collaborator-tested evidence for Flow Cyt. Read more ›
["FCM"]![Anti-Mouse F4/80 Antibody [BM8]](http://www.abmium.com/cdn/shop/files/Screenshot_2026-06-08_210431_bbb3e9c8-5dc2-4749-b422-9807abaf4bdb.png?v=1781040744&width=160)
Product Description
F4/80 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Mouse; host: Rat; clonality: Monoclonal; clone: BM8; isotype: Rat IgG2a, κ; available conjugation options: None (AF/LE), Unconjugated.
Application evidence: Elabscience lists this product for FCM. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Mouse F4/80 protein; purification: >98%, Protein A/G purified; concentration: ≥ 1 mg/mL.
Database references: UniProt: Q61549.
Research Use Only.
Key Facts
| Target | F4/80 |
| Also known as | Emr, EGF-TM7, Emr1, F4/80, Gpf480, Ly71, TM7LN3, F4/, Gpf, EGF-like module receptor, Cell surface glycoprotein F4/, Adhesion G protein-coupled receptor E, DD7A5, TM7LN, Adgre, EGF-TM, DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71, TM7LN3, Adhesion G protein-coupled receptor E1, Cell surface glycoprotein F4/80, EGF-like module receptor 1, Adgre1 |
| Concentration | ≥ 1 mg/mL |
| Species reactivity | Mouse |
| Purity | >98% |
| Shelf life | 12 months from shipping dates |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Mouse |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.